Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NCT07480902 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 558
Last updated 2026-03-18
Summary
This study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to detect precursor lesions and cervical cancer among women of an open population
Conditions
- I) Atypical Squamous Cells of Undetermined Significance (ASC-US)
- II) Atypical Glandular Cells of Uncertain Significance (AGUS)
- III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3
- IV) Low-grade Squamous Intraepithelial Lesion (LSIL)
- V) High-grade Squamous Intraepithelial Lesion (HSIL)
- VI) Cervical Cancer
Interventions
- OTHER
-
Liquid-based cytology
Screening test for cervical precursor lesions and/or cancer. LBC is a procedure in which a cervical smear is examined under the microscope
- PROCEDURE
-
Physical examination
Physical examination and interview for obtaining a medical record of each participant
- OTHER
-
Molecular screening
The molecular screening detects three human biomarkers associated with cervical precursor lesions and/or cervical cancer. Biomarker detection is done by Western blot and ELISA in human sera
- OTHER
-
HPV DNA test
HPV DNA detection is performed using a cervical swab
- DIAGNOSTIC_TEST
-
Colposcopy
A diagnostic procedure to visually examine the cervix, vagina, and vulva with a colposcope
- DIAGNOSTIC_TEST
-
Histopathology
Is the definitive diagnosis of cervical precursor lesions and cervical cancer. It is the microscopic study of diseased cells and tissues stained with hematoxylin and eosin
Sponsors & Collaborators
-
Timser SAPI de CV
lead INDUSTRY
Principal Investigators
-
Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol · Consultorio Médico TIMSER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-03
- Primary Completion
- 2026-04-30
- Completion
- 2026-06-30
Countries
- Mexico
Study Locations
More Related Trials
-
Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
NCT05851079 ·Status: UNKNOWN
-
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
NCT04072913 ·Status: COMPLETED ·Phase: NA
-
iMproving thE DIagnostics And Treatment Of ceRvical Precancer
NCT05870787 ·Status: COMPLETED
-
DNA Methylation for Screening Uterine Cervical Lesions
NCT03960879 ·Status: UNKNOWN
-
Cervical Cancer Screening Strategies
NCT05309122 ·Status: UNKNOWN
-
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 ·Status: COMPLETED
-
Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions
NCT02238990 ·Status: ACTIVE_NOT_RECRUITING
-
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
NCT01837693 ·Status: COMPLETED ·Phase: NA
-
chemQbiosciences:Manual Liquid Based Cytology
NCT01837303 ·Status: COMPLETED
-
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561 ·Status: RECRUITING
-
Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia
NCT02067468 ·Status: COMPLETED ·Phase: NA
-
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635 ·Status: ACTIVE_NOT_RECRUITING
-
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 ·Status: RECRUITING
-
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
NCT07453459 ·Status: RECRUITING ·Phase: NA
-
Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects
NCT00937950 ·Status: COMPLETED ·Phase: PHASE3
-
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
NCT01550783 ·Status: COMPLETED ·Phase: NA
-
Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
NCT04274465 ·Status: COMPLETED
-
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
NCT07214584 ·Status: RECRUITING
-
Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil
NCT03713697 ·Status: COMPLETED ·Phase: NA
-
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
NCT05046080 ·Status: RECRUITING
-
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
NCT03638427 ·Status: COMPLETED
-
Genotypification and Predisposing Factors in Human Papilloma Virus Infection
NCT01924117 ·Status: COMPLETED ·Phase: NA
-
Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women
NCT07250841 ·Status: COMPLETED
-
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
NCT07186530 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia
NCT00602368 ·Status: COMPLETED ·Phase: NA